Medical Properties Trust, Inc.

MPTNYSECIK 1287865Real Estate / REITsfiscal year ends December67 quarters since 2010

Revenue, Q3 FY2026
$250M
+5.3% on Q3 FY2025
Net income
$202M
+359.3% on Q3 FY2025
Free cash flow
—
no year-earlier figure
Diluted EPS
$0.34
+361.5% on Q3 FY2025
Revenue, TTM
$1.0B
trailing four quarters
Net margin, TTM
24.1%
net income $249M
Free cash flow, TTM
—
Cash and equivalents
$599M
long-term debt $9.3B, Sep 30, 2026
Shares, 12-month change
−2.1%
589M shares, Sep 30, 2026
Buybacks, TTM
—
no yield
Dividends, TTM
$212M
21.6% of market value
Market value
$983M
at the close, buybacks

Latest quarter Q3 FY2026, filed November 6, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q3 FY2026, the quarter ended September 30, 2026, Medical Properties Trust, Inc. reported revenue of $250M, +5.3% on Q3 FY2025, and net income of $202M (+359.3%). Diluted earnings per share were $0.34.

Share price

Daily candlesticks from November 18, 2024 to November 13, 2026, with each earnings release marked; a release after the close marks the day it came out, so its reaction is the next candle. See this earnings season for every company’s reaction.

MPT daily priceSplit-adjusted, US dollars; an earnings release
Nov 13, 2026O $1.69 · H $1.73 · L $1.62 · C $1.67 · −2.34% on the dayOver the range: −66.47%, Nov 14, 2025 to Nov 13, 2026
$1.33$2.69$4.04$5.40$6.76Nov 25Jan 26Apr 26Jun 26Sep 26Nov 26

The last 16 quarters

Q4 FY2022 to Q3 FY2026, through the filing of November 6, 2026.

Revenue and net incomeRevenueNet income
−$1.0B−$500M$0$500MQ4'22, Revenue: $380MQ4'22, Net income: −$140MQ4'22Q1'23, Revenue: $350MQ1'23, Net income: $33MQ1'23Q2'23, Revenue: $337MQ2'23, Net income: −$42MQ2'23Q3'23, Revenue: $307MQ3'23, Net income: $117MQ3'23Q4'23, Revenue: −$122MQ4'23, Net income: −$664MQ4'23Q1'24, Revenue: $271MQ1'24, Net income: −$876MQ1'24Q2'24, Revenue: $267MQ2'24, Net income: −$321MQ2'24Q3'24, Revenue: $226MQ3'24, Net income: −$801MQ3'24Q4'24, Revenue: $232MQ4'24, Net income: −$413MQ4'24Q1'25, Revenue: $224MQ1'25, Net income: −$118MQ1'25Q2'25, Revenue: $240MQ2'25, Net income: −$98MQ2'25Q3'25, Revenue: $238MQ3'25, Net income: −$78MQ3'25Q4'25, Revenue: $270MQ4'25, Net income: $17MQ4'25Q1'26, Revenue: $252MQ1'26, Net income: $33MQ1'26Q2'26, Revenue: $259MQ2'26, Net income: −$3MQ2'26Q3'26, Revenue: $250MQ3'26, Net income: $202MQ3'26−$1.0B−$500M$0$500MQ4'22, Revenue: $380MQ4'22, Net income: −$140MQ4'22Q1'23, Revenue: $350MQ1'23, Net income: $33MQ1'23Q2'23, Revenue: $337MQ2'23, Net income: −$42MQ2'23Q3'23, Revenue: $307MQ3'23, Net income: $117MQ3'23Q4'23, Revenue: −$122MQ4'23, Net income: −$664MQ4'23Q1'24, Revenue: $271MQ1'24, Net income: −$876MQ1'24Q2'24, Revenue: $267MQ2'24, Net income: −$321MQ2'24Q3'24, Revenue: $226MQ3'24, Net income: −$801MQ3'24Q4'24, Revenue: $232MQ4'24, Net income: −$413MQ4'24Q1'25, Revenue: $224MQ1'25, Net income: −$118MQ1'25Q2'25, Revenue: $240MQ2'25, Net income: −$98MQ2'25Q3'25, Revenue: $238MQ3'25, Net income: −$78MQ3'25Q4'25, Revenue: $270MQ4'25, Net income: $17MQ4'25Q1'26, Revenue: $252MQ1'26, Net income: $33MQ1'26Q2'26, Revenue: $259MQ2'26, Net income: −$3MQ2'26Q3'26, Revenue: $250MQ3'26, Net income: $202MQ3'26−$1.0B−$500M$0$500MQ4'22, Revenue: $380MQ4'22, Net income: −$140MQ1'23, Revenue: $350MQ1'23, Net income: $33MQ1'23Q2'23, Revenue: $337MQ2'23, Net income: −$42MQ3'23, Revenue: $307MQ3'23, Net income: $117MQ3'23Q4'23, Revenue: −$122MQ4'23, Net income: −$664MQ1'24, Revenue: $271MQ1'24, Net income: −$876MQ1'24Q2'24, Revenue: $267MQ2'24, Net income: −$321MQ3'24, Revenue: $226MQ3'24, Net income: −$801MQ3'24Q4'24, Revenue: $232MQ4'24, Net income: −$413MQ1'25, Revenue: $224MQ1'25, Net income: −$118MQ1'25Q2'25, Revenue: $240MQ2'25, Net income: −$98MQ3'25, Revenue: $238MQ3'25, Net income: −$78MQ3'25Q4'25, Revenue: $270MQ4'25, Net income: $17MQ1'26, Revenue: $252MQ1'26, Net income: $33MQ1'26Q2'26, Revenue: $259MQ2'26, Net income: −$3MQ3'26, Revenue: $250MQ3'26, Net income: $202MQ3'26

Net income losses drawn in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$5B$10B$15BQ4'22, Cash and equivalents: $236MQ4'22, Long-term debt: $10.3BQ4'22Q1'23, Cash and equivalents: $302MQ1'23, Long-term debt: $10.4BQ1'23Q2'23, Cash and equivalents: $324MQ2'23, Long-term debt: $10.2BQ2'23Q3'23, Cash and equivalents: $340MQ3'23, Long-term debt: $10.2BQ3'23Q4'23, Cash and equivalents: $250MQ4'23, Long-term debt: $10.1BQ4'23Q1'24, Cash and equivalents: $224MQ1'24, Long-term debt: $10.1BQ1'24Q2'24, Cash and equivalents: $607MQ2'24, Long-term debt: $9.4BQ2'24Q3'24, Cash and equivalents: $276MQ3'24, Long-term debt: $9.2BQ3'24Q4'24, Cash and equivalents: $332MQ4'24, Long-term debt: $8.8BQ4'24Q1'25, Cash and equivalents: $673MQ1'25, Long-term debt: $9.5BQ1'25Q2'25, Cash and equivalents: $510MQ2'25, Long-term debt: $9.6BQ2'25Q3'25, Cash and equivalents: $397MQ3'25, Long-term debt: $9.6BQ3'25Q4'25, Cash and equivalents: $541MQ4'25, Long-term debt: $9.7BQ4'25Q1'26, Cash and equivalents: $425MQ1'26, Long-term debt: $9.7BQ1'26Q2'26, Cash and equivalents: $397MQ2'26, Long-term debt: $9.7BQ2'26Q3'26, Cash and equivalents: $599MQ3'26, Long-term debt: $9.3BQ3'26$0$5B$10B$15BQ4'22, Cash and equivalents: $236MQ4'22, Long-term debt: $10.3BQ4'22Q1'23, Cash and equivalents: $302MQ1'23, Long-term debt: $10.4BQ1'23Q2'23, Cash and equivalents: $324MQ2'23, Long-term debt: $10.2BQ2'23Q3'23, Cash and equivalents: $340MQ3'23, Long-term debt: $10.2BQ3'23Q4'23, Cash and equivalents: $250MQ4'23, Long-term debt: $10.1BQ4'23Q1'24, Cash and equivalents: $224MQ1'24, Long-term debt: $10.1BQ1'24Q2'24, Cash and equivalents: $607MQ2'24, Long-term debt: $9.4BQ2'24Q3'24, Cash and equivalents: $276MQ3'24, Long-term debt: $9.2BQ3'24Q4'24, Cash and equivalents: $332MQ4'24, Long-term debt: $8.8BQ4'24Q1'25, Cash and equivalents: $673MQ1'25, Long-term debt: $9.5BQ1'25Q2'25, Cash and equivalents: $510MQ2'25, Long-term debt: $9.6BQ2'25Q3'25, Cash and equivalents: $397MQ3'25, Long-term debt: $9.6BQ3'25Q4'25, Cash and equivalents: $541MQ4'25, Long-term debt: $9.7BQ4'25Q1'26, Cash and equivalents: $425MQ1'26, Long-term debt: $9.7BQ1'26Q2'26, Cash and equivalents: $397MQ2'26, Long-term debt: $9.7BQ2'26Q3'26, Cash and equivalents: $599MQ3'26, Long-term debt: $9.3BQ3'26$0$5B$10B$15BQ4'22, Cash and equivalents: $236MQ4'22, Long-term debt: $10.3BQ1'23, Cash and equivalents: $302MQ1'23, Long-term debt: $10.4BQ1'23Q2'23, Cash and equivalents: $324MQ2'23, Long-term debt: $10.2BQ3'23, Cash and equivalents: $340MQ3'23, Long-term debt: $10.2BQ3'23Q4'23, Cash and equivalents: $250MQ4'23, Long-term debt: $10.1BQ1'24, Cash and equivalents: $224MQ1'24, Long-term debt: $10.1BQ1'24Q2'24, Cash and equivalents: $607MQ2'24, Long-term debt: $9.4BQ3'24, Cash and equivalents: $276MQ3'24, Long-term debt: $9.2BQ3'24Q4'24, Cash and equivalents: $332MQ4'24, Long-term debt: $8.8BQ1'25, Cash and equivalents: $673MQ1'25, Long-term debt: $9.5BQ1'25Q2'25, Cash and equivalents: $510MQ2'25, Long-term debt: $9.6BQ3'25, Cash and equivalents: $397MQ3'25, Long-term debt: $9.6BQ3'25Q4'25, Cash and equivalents: $541MQ4'25, Long-term debt: $9.7BQ1'26, Cash and equivalents: $425MQ1'26, Long-term debt: $9.7BQ1'26Q2'26, Cash and equivalents: $397MQ2'26, Long-term debt: $9.7BQ3'26, Cash and equivalents: $599MQ3'26, Long-term debt: $9.3BQ3'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q3 FY2026 filed November 6, 2026.

Medical Properties Trust, Inc. income statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Nov 6, 2026Q2 FY2026ended Jun 30, 2026filed Aug 10, 2026Q1 FY2026ended Mar 31, 2026filed May 8, 2026Q4 FY2025ended Dec 31, 2025filed Feb 26, 2026Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025Q2 FY2025ended Jun 30, 2025filed Aug 8, 2025Q1 FY2025ended Mar 31, 2025filed May 9, 2025Q4 FY2024ended Dec 31, 2024filed Mar 3, 2025YoYQ3 FY2026vs Q3 FY2025
Revenue250259252270238240224232+5.3%
Cost of revenue(33)129711(22)208121−46.2%
Gross profit—————————
Research and development—————————
Selling, general and administrative2935322538264228−23.1%
Operating income—————————
Other income (expense)226(1)(7)(11)(58)(95)(103)(430)+489.5%
Pretax income2128026(67)(88)(109)(403)+418.6%
Income tax1010(33)91110910−7.8%
Net income202(3)3317(78)(98)(118)(413)+359.3%
Diluted EPS ($)0.34(0.01)0.05—(0.13)(0.16)(0.20)—+361.5%
Diluted shares (millions)597598598—601601601——

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q3 FY2026 filed November 6, 2026.

Medical Properties Trust, Inc. balance sheet, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Nov 6, 2026Q2 FY2026ended Jun 30, 2026filed Aug 10, 2026Q1 FY2026ended Mar 31, 2026filed May 8, 2026Q4 FY2025ended Dec 31, 2025filed Feb 26, 2026Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025Q2 FY2025ended Jun 30, 2025filed Aug 8, 2025Q1 FY2025ended Mar 31, 2025filed May 9, 2025Q4 FY2024ended Dec 31, 2024filed Mar 3, 2025YoYQ3 FY2026vs Q3 FY2025
Cash and equivalents599397425541397510673332+51.1%
Short-term investments—————————
Total current assets—————————
Total assets14,39414,74814,76315,00214,92415,15014,85414,295−3.6%
Total current liabilities—————————
Long-term debt9,2609,7059,6639,6989,6169,6499,4658,848−3.7%
Total debt9,2609,7059,6639,6989,6169,6499,4658,848−3.7%
Total liabilities9,77110,24810,21710,39510,26310,31710,0929,461−4.8%
Stockholders’ equity4,6214,4994,5454,6064,6604,8334,7614,833−0.8%
Shares outstanding (millions)589597598598602601601601—

Positions at each period end. Long-term debt is the line the filer tags, with or without its current portion. Total debt is one definition across filers, built from filed lines: long-term debt with its current portion plus short-term borrowings, finance leases where the filer folds them into its debt line, operating leases never; it is blank where the tags do not add up to it. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q3 FY2026 filed November 6, 2026.

Medical Properties Trust, Inc. cash flow statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Nov 6, 2026Q2 FY2026ended Jun 30, 2026filed Aug 10, 2026Q1 FY2026ended Mar 31, 2026filed May 8, 2026Q4 FY2025ended Dec 31, 2025filed Feb 26, 2026Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025Q2 FY2025ended Jun 30, 2025filed Aug 8, 2025Q1 FY2025ended Mar 31, 2025filed May 9, 2025Q4 FY2024ended Dec 31, 2024filed Mar 3, 2025YoYQ3 FY2026vs Q3 FY2025
Operating cash flow4162(14)1601952077+121.5%
Capital expenditures—————————
Free cash flow (CFO − capex)—————————
Depreciation and amortization706973withheldwithheldwithheldwithheld66—
Share repurchases0——230————
Dividends paid5454554848484848+12.2%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 26, 2026.

Income statement

Medical Properties Trust, Inc. income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 26, 2026FY2024ended Dec 31, 2024filed Mar 3, 2025FY2023ended Dec 31, 2023filed Feb 29, 2024FY2022ended Dec 31, 2022filed Mar 1, 2023FY2021ended Dec 31, 2021filed Mar 1, 2022FY2020ended Dec 31, 2020filed Mar 1, 2021FY2019ended Dec 31, 2019filed Feb 27, 2020FY2018ended Dec 31, 2018filed Mar 1, 2019FY2017ended Dec 31, 2017filed Mar 1, 2018FY2016ended Dec 31, 2016filed Mar 1, 2017FY2015ended Dec 31, 2015filed Feb 29, 2016FY2014ended Dec 31, 2014filed Mar 2, 2015FY2013ended Dec 31, 2013filed Mar 3, 2014FY2012ended Dec 31, 2012filed Feb 22, 2013FY2011ended Dec 31, 2011filed Feb 29, 2012FY2010ended Dec 31, 2010filed May 10, 2011FY2009ended Dec 31, 2009filed May 10, 2011
Revenue9729968721,5431,5451,249854785705541442313243198132108114
Cost of revenue90741101671013016884—————————
Gross profit—————————————————
Research and development—————————————————
Selling, general and administrative1301341461601461329681594944373029272721
Operating income————————486342263143154130704268
Other income (expense)(267)(2,333)(357)31560(36)30681(15)30(123)(92)(64)(57)(58)(39)(38)
Pretax income(237)(2,364)(687)9607314633741,019294219141519073———
Income tax3944(131)567431(3)13(7)2010020
Net income(277)(2,410)(556)9036564313751,017290225140519790272336
Diluted EPS ($)(0.46)(4.02)(0.93)1.501.110.810.872.760.820.860.630.290.630.670.230.220.45
Diluted shares (millions)60160059959959053042836635026121817115313211110178

Balance sheet

Medical Properties Trust, Inc. balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 26, 2026FY2024ended Dec 31, 2024filed Mar 3, 2025FY2023ended Dec 31, 2023filed Feb 29, 2024FY2022ended Dec 31, 2022filed Mar 1, 2023FY2021ended Dec 31, 2021filed Mar 1, 2022FY2020ended Dec 31, 2020filed Mar 1, 2021FY2019ended Dec 31, 2019filed Feb 27, 2020FY2018ended Dec 31, 2018filed Mar 1, 2019FY2017ended Dec 31, 2017filed Mar 1, 2018FY2016ended Dec 31, 2016filed Mar 1, 2017FY2015ended Dec 31, 2015filed Feb 29, 2016FY2014ended Dec 31, 2014filed Mar 2, 2015FY2013ended Dec 31, 2013filed Mar 3, 2014FY2012ended Dec 31, 2012filed Feb 22, 2013FY2011ended Dec 31, 2011filed Feb 29, 2012FY2010ended Dec 31, 2010filed May 10, 2011FY2009ended Dec 31, 2009filed May 10, 2011
Cash and equivalents5413322502364595501,4628211718319614546371039815
Short-term investments—————————————————
Total current assets—————————————————
Total assets15,00214,29518,30519,65820,52016,82914,4678,8449,0206,4195,6093,7202,9052,1791,6221,349—
Total current liabilities—————————————————
Long-term debt9,6988,84810,06410,26811,2838,8657,0244,0374,8992,9093,3492,1991,4221,025690370—
Total debt9,6988,84810,06410,26811,2838,8657,0244,0374,8992,9093,3492,1991,4221,025690370—
Total liabilities10,3959,46110,67111,06412,0749,4857,4394,2835,1853,1653,5022,3381,5601,129793449—
Stockholders’ equity4,6064,8337,6328,5938,4407,3397,0284,5473,8213,2482,1021,3821,3441,050829899—
Shares outstanding (millions)598601599598600580521381365321238209163137135——

Cash flow statement

Medical Properties Trust, Inc. cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 26, 2026FY2024ended Dec 31, 2024filed Mar 3, 2025FY2023ended Dec 31, 2023filed Feb 29, 2024FY2022ended Dec 31, 2022filed Mar 1, 2023FY2021ended Dec 31, 2021filed Mar 1, 2022FY2020ended Dec 31, 2020filed Mar 1, 2021FY2019ended Dec 31, 2019filed Feb 27, 2020FY2018ended Dec 31, 2018filed Mar 1, 2019FY2017ended Dec 31, 2017filed Mar 1, 2018FY2016ended Dec 31, 2016filed Mar 1, 2017FY2015ended Dec 31, 2015filed Feb 29, 2016FY2014ended Dec 31, 2014filed Mar 2, 2015FY2013ended Dec 31, 2013filed Mar 3, 2014FY2012ended Dec 31, 2012filed Feb 22, 2013FY2011ended Dec 31, 2011filed Feb 29, 2012FY2010ended Dec 31, 2010filed May 10, 2011FY2009ended Dec 31, 2009filed May 10, 2011
Operating cash flow231245506739812618494449362264207150141105796163
Capital expenditures—————————————————
Free cash flow (CFO − capex)—————————————————
Depreciation and amortization2734546163463342761571411329872553936352626
Share repurchases23——18—————————————
Dividends paid193321615699643568412364327218183144120104907762

Insider activity

Form 4 filings by officers, directors and 10% owners, November 16, 2024 to November 16, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$10K
1 purchases by 1 insider; officers and directors $10K
Sold, three months
$0
0 sales by 0 insiders; officers and directors $0
Bought, twelve months
$10K
1 purchases by 1 insider; officers and directors $10K
Sold, twelve months
$306K
2 sales by 2 insiders; officers and directors $306K

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 7, 2026Aldag Edward K JRChairman, President & CEO, Directortax withholding109,433$3.51$384K7MOct 7, 2026
Oct 7, 2026Hamner R StevenExecutive Vice President & CFO, Directortax withholding48,548$3.51$170K4MOct 7, 2026
Oct 7, 2026Portal Larry HSVP, Senior Advisor to the CEOtax withholding4,048$3.51$14K570,980Oct 7, 2026
Oct 7, 2026Hanna James KevinSenior VP, Controller & CAOtax withholding3,295$3.51$12K539,209Oct 7, 2026
Oct 7, 2026Williams Rosa HandleySVP of Operationstax withholding1,938$3.51$7K446,960Oct 7, 2026
Oct 7, 2026Lambert Charles RSVP of Finance and Treasurertax withholding2,347$3.51$8K385,360Oct 7, 2026
Aug 20, 2026Hanna James KevinSenior VP, Controller & CAOopen-market buy2,300$4.15$10K542,504Aug 20, 2026
Jul 8, 2026Lambert Charles RSVP of Finance and Treasurertax withholding2,347$4.61$11K387,707Jul 8, 2026
Jul 8, 2026Portal Larry HSVP, Senior Advisor to the CEOtax withholding4,048$4.61$19K575,028Jul 8, 2026
Jul 8, 2026Aldag Edward K JRChairman, President & CEO, Directortax withholding109,433$4.61$504K7MJul 8, 2026
Jul 8, 2026Hamner R StevenExecutive Vice President & CFO, Directortax withholding48,548$4.61$224K4MJul 8, 2026
Jul 8, 2026Hanna James KevinSenior VP, Controller & CAOtax withholding3,295$4.61$15K540,204Jul 8, 2026
Jul 8, 2026Williams Rosa HandleySVP of Operationstax withholding1,938$4.61$9K448,898Jul 8, 2026
Apr 8, 2026Aldag Edward K JRChairman, President & CEO, Directortax withholding109,433$4.67$511K7MApr 8, 2026
Apr 8, 2026Hamner R StevenExecutive Vice President & CFO, Directortax withholding48,548$4.67$227K4MApr 8, 2026
Apr 8, 2026Portal Larry HSVP, Senior Advisor to the CEOtax withholding4,048$4.67$19K579,076Apr 8, 2026
Apr 8, 2026Lambert Charles RSVP of Finance and Treasurertax withholding2,347$4.67$11K390,054Apr 8, 2026
Apr 8, 2026Williams Rosa HandleySVP of Operationstax withholding1,938$4.67$9K450,836Apr 8, 2026
Apr 8, 2026Hanna James KevinSenior VP, Controller & CAOtax withholding3,295$4.67$15K543,499Apr 8, 2026
Mar 18, 2026Williams Rosa HandleySVP of Operationsaward21,250$0.00—452,774Mar 19, 2026
Mar 18, 2026Williams Rosa HandleySVP of Operationsaward42,500$0.00—431,524Mar 19, 2026
Mar 18, 2026Portal Larry HSVP, Senior Advisor to the CEOaward37,500$0.00—583,124Mar 19, 2026
Mar 18, 2026Portal Larry HSVP, Senior Advisor to the CEOaward75,000$0.00—545,624Mar 19, 2026
Mar 18, 2026Lambert Charles RSVP of Finance and Treasureraward50,000$0.00—367,401Mar 19, 2026
Mar 18, 2026Lambert Charles RSVP of Finance and Treasureraward25,000$0.00—392,401Mar 19, 2026

Full insider history for Medical Properties Trust, Inc., or insider activity across all companies. A record of filings, not a recommendation.

Tracked funds holding it

1 of the tracked managers held MPT in their latest 13F filing, through November 12, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded MPT by quarter.

FundManagerQuarterValueSharesWeightMove
Renaissance TechnologiesPeter BrownQ3 2026$292K84,4000.00%new

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
MEDICAL PROPERTIES TRUST INC, CIK 1287865 on EDGAR
Extract generated
November 16, 2026
Withheld
17 line-years whose four quarters do not sum to the filed year: depreciation amortization FY2010, depreciation amortization FY2011, revenue FY2011, depreciation amortization FY2012, depreciation amortization FY2013, depreciation amortization FY2014, depreciation amortization FY2015, depreciation amortization FY2016, depreciation amortization FY2017, depreciation amortization FY2018, depreciation amortization FY2019, depreciation amortization FY2020, depreciation amortization FY2021, depreciation amortization FY2022, income tax FY2022, depreciation amortization FY2023, depreciation amortization FY2025
Repaired
2 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: income tax FY2018, other income FY2022
XBRL concepts behind each line

Income statement

Revenue: Revenues
Cost of revenue: CostOfGoodsAndServicesSold
Gross profit: not filed
Research and development: not filed
Selling, general and administrative: GeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): NonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: not filed
Total current assets: not filed
Total assets: Assets
Total current liabilities: not filed
Long-term debt: LongTermDebt
Total debt: LongTermDebt
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: not filed
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationAndAmortization, DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfOrdinaryDividends

The data

The statements on this page as files, generated November 16, 2026.

JSON file
/data/financials/MPT.json